Cipla Limited:企業の戦略・SWOT・財務分析

◆英語タイトル:Cipla Limited - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4849
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Cipla Limited – Strategy, SWOT and Corporate Finance Report
Summary

Cipla Limited – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Cipla Limited (Cipla or ‘the company’) is a manufacturer of prescription drugs, veterinary and active pharmaceutical ingredient products. The company provides products for various therapeutic categories including dermatology, critical care, cardiovascular, infectious diseases, children’s health, and cosmetology, HIV/AIDS, diabetes, neurosciences, hepatitis, malaria, oncology, ophthalmology, respiratory, osteoporosis and urology. The company is also engaged in biosimilar and consumer healthcare. Cipla operates state-of-the-art research facilities for API process development in India and has dedicated cancer and polypeptide development laboratories. The company offers its products in South Africa, India, and North America and other markets. Cipla is headquartered in Mumbai, Maharashtra, India.

Scope

- Detailed information on Cipla Limited required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Cipla Limited in the form of a SWOT analysis
- An in-depth view of the business model of Cipla Limited including a breakdown and examination of key business segments
- Intelligence on Cipla Limited’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Cipla Limited, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Cipla Limited and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Cipla Limited as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Cipla Limited’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Cipla Limited: Company Overview
Cipla Limited: Overview and Key Facts
Cipla Limited: Overview
Cipla Limited: Key Facts
Cipla Limited: Key Employees
Cipla Limited: Key Employee Biographies
Cipla Limited: Major Products and Services
Cipla Limited: Company History
Cipla Limited: Management Statement
Cipla Limited: Locations and Subsidiaries
Cipla Limited: Key Competitors
Cipla Limited: Company Analysis
Cipla Limited: Business Description
Cipla Limited: SWOT Analysis
Cipla Limited: SWOT Overview
Cipla Limited: Strengths
Cipla Limited: Weaknesses
Cipla Limited: Opportunities
Cipla Limited: Threats
Cipla Limited: Corporate Financial Deals Activity
Cipla Limited: Financial Deals Overview
Cipla Limited: Targets and Partners
Cipla Limited: Top Deals 2016 – 2020YTD*
Cipla Limited: Mergers and Acquisitions
Cipla Limited: Capital Raising
Cipla Limited: Partnership
Cipla Limited: Divestments
Cipla Limited: Recent Developments
Cipla Limited: News and Events Summary
Cipla Limited: Contracts
Cipla Limited: Corporate Governance
Cipla Limited: Financial Deals
Cipla Limited: Financial Performance
Cipla Limited: Market Developments
Cipla Limited: Regulatory and Legal Events
Cipla Limited: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Cipla Limited: Key Facts
Table 2: Cipla Limited: Key Employees
Table 3: Cipla Limited: Company History
Table 4: Cipla Limited: Locations and Subsidiaries
Table 5: Cipla Limited: Key Competitors
Table 6: Cipla Limited: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Cipla Limited: M&A Activity by Geography (TTM*)
Table 8: Cipla Limited: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 9: Cipla Limited: M&A Average Deal Size - Value (US$m)
Table 10: Cipla Limited: Targets and Partners
Table 11: Cipla Limited: Top Deals 2016 - 2020YTD*
Table 12: Cipla Limited: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Cipla Limited: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Cipla Limited: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 15: Cipla Limited: Capital Raising by Deal Type (2016 - YTD*2020)
Table 16: Cipla Limited: Partnership Volume and Value Trend (2016 - YTD*2020)
Table 17: Cipla Limited: Partnership Trend by Deal Type (2016 - YTD*2020)
Table 18: Cipla Limited: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 19: Cipla Limited: Divestments by Geography (2016 - YTD*2020)
Table 20: Cipla Limited: News and Events Summary
Table 21: Cipla Limited: Contracts
Table 22: Cipla Limited: Corporate Governance
Table 23: Cipla Limited: Financial Deals
Table 24: Cipla Limited: Financial Performance
Table 25: Cipla Limited: Market Developments
Table 26: Cipla Limited: Regulatory and Legal Events
Table 27: Cipla Limited: Strategy and Operations

★海外企業調査レポート[Cipla Limited:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tata Chemicals Ltd (TATACHEM):企業の財務・戦略的SWOT分析
    Summary Tata Chemicals Ltd (TCL) is a chemical company engaged in offering industry, living, and farm essential chemicals. The company's products include dals, consumer salt, water purifier, soda ash, spices, sodium bicarbonate, allied chemicals, industrial salt, customized fertilizers, cement, fert …
  • FUJIFILM Medical Systems USA Inc:企業の戦略的SWOT分析
    FUJIFILM Medical Systems USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Karolinska Development AB (KDEV):製薬・医療:M&Aディール及び事業提携情報
    Summary Karolinska Development AB (Karolinska Development) is a life sciences investment company that develops innovations from science into commercial products. The company invests in start up's and growth of the pharmaceutical, medical device and biotechnology companies that develop specialty care …
  • Manz AG (M5Z)-エネルギー分野:企業M&A・提携分析
    Summary Manz AG (Manz) is a manufacturer of high-technology equipment. It produces displays, printed circuit boards and other components for electronic devices. The company provides production equipment for lithium-ion battery cells, super capacitors, battery systems, and capacitors. Manz offers ind …
  • ITV plc (ITV):企業の財務・戦略的SWOT分析
    ITV plc (ITV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • RWE AG (RWE):企業の財務・戦略的SWOT分析
    RWE AG (RWE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • BioClinica Inc:企業の戦略的SWOT分析
    BioClinica Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • OAO Lukoil:企業のM&A・事業提携・投資動向
    OAO Lukoil - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's OAO Lukoil Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Autonomous University of Barcelona:製薬・医療:M&Aディール及び事業提携情報
    Summary Autonomous University of Barcelona (UAB) is a public university that offers education, research and knowledge transfer services. The university provides undergraduate, post graduate, masters, doctorates, and foreign undergraduate programs. It offers educational programs in the areas of arts …
  • Absorption Systems LP-医療機器分野:企業M&A・提携分析
    Summary Absorption Systems LP (Absorption Systems) is a pre-clinical contract research organization that develops and implements research tools. The organization carries out preclinical testing of drugs, biologics, and medical devices. It develops and implements research tools to predict human outco …
  • Far East Consortium International Ltd:企業の戦略・SWOT・財務情報
    Far East Consortium International Ltd - Strategy, SWOT and Corporate Finance Report Summary Far East Consortium International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Christian Dior SE:戦略・SWOT・企業財務分析
    Christian Dior SE - Strategy, SWOT and Corporate Finance Report Summary Christian Dior SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Otter Tail Corp:企業の発電所・SWOT分析2018
    Otter Tail Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Hoag Hospital Foundation:企業の戦略的SWOT分析
    Hoag Hospital Foundation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • LeasePlan Corporation N.V.:戦略・SWOT・企業財務分析
    LeasePlan Corporation N.V. - Strategy, SWOT and Corporate Finance Report Summary LeasePlan Corporation N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The Greenbrier Companies Inc:企業の戦略・SWOT・財務情報
    The Greenbrier Companies Inc - Strategy, SWOT and Corporate Finance Report Summary The Greenbrier Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • CDI Corp:企業の戦略的SWOT分析
    CDI Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Atmos Energy Corp:企業の財務・戦略的SWOT分析
    Atmos Energy Corp - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Alnylam Pharmaceuticals Inc (ALNY)-製薬・医療分野:企業M&A・提携分析
    Summary Alnylam Pharmaceuticals Inc, (Alnylam) is a biopharmaceutical company which discovers, develops and commercializes therapeutics based on Ribo Nucleic Acid interference (RNAi). The company offers a broad pipeline of investigational RNAi therapeutics in the areas of genetic medicines; cardiova …
  • European Institute of Oncology-製薬・医療分野:企業M&A・提携分析
    Summary European Institute of Oncology (IEO) is a research institute that conducts clinical and scientific research on cancer prevention, early diagnosis and treatment of cancer. The institute offers medical care services for breast tumors, lung tumors, cervical tumors, endometrial tumors, thoracic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆